GoodRx Holdings, Inc. - Class A (GDRX)
GDRX moved a median of +0.07% 30 minutes after news, and +0.28% by the close. How GDRX actually reacts to news — the realized, point-in-time move the market made, measured across 850 labeled events over the last three years with zero look-ahead.
GDRX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 46% | 845 |
| 30-min | +0.07% | 52% | 846 |
| 60-min | +0.15% | 57% | 846 |
| to close | +0.28% | 53% | 848 |
| Middle 50% of GDRX reactions | -0.55% to +1.08% |
|---|---|
| Median reaction (30-min) | +0.07% |
| Measured reactions | 850 |
Half of all GoodRx Holdings, Inc. - Class A news events land between -0.55% and +1.08% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How GDRX reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 19 | -0.70% | 47% | +0.48% |
| Analyst downgrades | 16 | -0.29% | 44% | -2.64% |
| Rating reiterations | 66 | -0.17% | 41% | +0.18% |
| Price-target raises | 14 | +0.36% | 57% | +0.30% |
| Price-target cuts | 25 | +0.10% | 56% | 0.00% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 1 further class was observed with fewer than 10 measured events and is not published. See how GDRX ranks against every other measured name →
That’s how GDRX usually reacts — get an email when it moves on news →Email me when GDRX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to GDRX's baseline. Nothing else.
Recent GDRX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household | Press release | Business Wire | +1.58% | +1.44% | |
| Form 10-Q GoodRx Holdings, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.75% | +8.77% | |
| Form 8-K GoodRx Holdings, Inc. For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | -1.75% | +8.77% | |
| Form 8-K GoodRx Holdings, Inc. For: Jul 31 | SEC filing · Form 8-K | SEC EDGAR | -1.75% | +8.77% | |
| GoodRx Reports Second Quarter 2026 Results | Press release | Business Wire | -1.75% | +8.77% | |
| GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call | Press release | Business Wire | +0.34% | -0.34% | |
| Form 8-K GoodRx Holdings, Inc. For: Jun 16 | SEC filing · Form 8-K | SEC EDGAR | +0.38% | -2.65% | |
| GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs | Press release | Business Wire | -1.95% | +2.88% | |
| Form 10-Q GoodRx Holdings, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +5.58% | +13.15% | |
| Form 8-K GoodRx Holdings, Inc. For: May 06 | SEC filing · Form 8-K | SEC EDGAR | +5.58% | +13.15% | |
| GoodRx Reports First Quarter 2026 Results | Press release | Business Wire | +5.58% | +13.15% | |
| GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients | Press release | Business Wire | -0.21% | +8.05% | |
| Form ARS GoodRx Holdings, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -0.43% | +2.61% | |
| Form DEF 14A GoodRx Holdings, Inc. For: Dec 31 | SEC filing · Form DEF | SEC EDGAR | -0.43% | +2.61% | |
| Form DEFA14A GoodRx Holdings, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | -0.43% | +2.61% | |
| Form 8-K GoodRx Holdings, Inc. For: Apr 23 | SEC filing · Form 8-K | SEC EDGAR | +1.30% | -0.87% | |
| GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call | Press release | Business Wire | +0.88% | +4.41% | |
| GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price | Press release | Business Wire | +2.44% | +3.11% | |
| GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide | Press release | Business Wire | -2.31% | +0.00% | |
| Form 8-K GoodRx Holdings, Inc. For: Mar 31 | SEC filing · Form 8-K | SEC EDGAR | +0.98% | +1.97% | |
| Form 8-K GoodRx Holdings, Inc. For: Mar 24 | SEC filing · Form 8-K | SEC EDGAR | +1.05% | +0.00% | |
| Form 8-K GoodRx Holdings, Inc. For: Mar 14 | SEC filing · Form 8-K | SEC EDGAR | +0.70% | +0.00% | |
| GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications | Press release | Business Wire | -1.68% | -5.86% | |
| Form 8-K GoodRx Holdings, Inc. For: Mar 03 | SEC filing · Form 8-K | SEC EDGAR | +1.12% | +4.91% | |
| GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen® | Press release | Business Wire | +2.02% | +2.24% | |
| Form 8-K GoodRx Holdings, Inc. For: Feb 26 | SEC filing · Form 8-K | SEC EDGAR | +0.28% | +20.56% | |
| Form 10-K GoodRx Holdings, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -0.99% | -0.50% | |
| Form S-8 GoodRx Holdings, Inc. | SEC filing · Form S-8 | SEC EDGAR | -0.99% | -0.50% | |
| Form 8-K GoodRx Holdings, Inc. For: Feb 25 | SEC filing · Form 8-K | SEC EDGAR | -0.99% | -0.50% | |
| GoodRx Reports Fourth Quarter and Full Year 2025 Results | Press release | Business Wire | -0.99% | -0.50% | |
| GoodRx Expands Into Employer Market With Launch of “GoodRx Employer Direct” | Press release | Business Wire | +0.00% | +3.95% | |
| GoodRx Powers Pricing for Leading Brand Medications on TrumpRx | Press release | Business Wire | -3.93% | +6.55% | |
| GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale | Press release | Business Wire | +0.00% | +0.89% | |
| GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call | Press release | Business Wire | -0.64% | +3.00% | |
| Surescripts and GoodRx Partner to Advance Patient Price Transparency | Press release | Business Wire | -0.17% | -2.39% | |
| GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies | Press release | Business Wire | -0.53% | -2.10% | |
| GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill | Press release | Business Wire | +0.36% | +2.17% | |
| GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference | Press release | Business Wire | -0.36% | +0.36% | |
| Form 8-K GoodRx Holdings, Inc. For: Dec 09 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -4.58% | |
| GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy® | Press release | Business Wire | -0.34% | -3.72% | |
| Leapfin and Airwallex Partner to Power Smarter Revenue Accounting for Scaling Businesses | Press release | PR Web | -0.15% | -0.89% | |
| Form 10-Q GoodRx Holdings, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.15% | -0.89% | |
| Form 8-K GoodRx Holdings, Inc. For: Nov 04 | SEC filing · Form 8-K | SEC EDGAR | -0.15% | -0.89% | |
| GoodRx Reports Third Quarter 2025 Results | Press release | Business Wire | -0.15% | -0.89% | |
| Form 8-K GoodRx Holdings, Inc. For: Oct 31 | SEC filing · Form 8-K | SEC EDGAR | -0.15% | -0.31% | |
| GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment | Press release | Business Wire | -2.15% | -4.06% | |
| GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call | Press release | Business Wire | +0.23% | +4.27% | |
| GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings | Press release | Business Wire | +0.33% | -0.87% | |
| GoodRx Launches Brand Medication Savings Program at National Retail Pharmacy | Press release | Business Wire | +0.71% | +19.19% | |
| GoodRx Saddles Up With “The Savings Wrangler,” a Bold New Brand Campaign to Tame the Wild West of Prescription Pricing | Press release | Business Wire | +0.47% | +1.18% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the GDRX section they belong to.
Where else GDRX is measured.
GDRX earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is GoodRx Holdings, Inc. - Class A's median reaction calculated?
Every labeled GDRX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 850 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 52% of GDRX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does GDRX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.